2025. Design, Molecular Docking, Synthesis, Characterization and Preliminary Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Cyclin-Dependent Kinase 2 Inhibitors. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 1 (Jan. 2025), 94–109. DOI:https://doi.org/10.32947/ajps.v25i1.1132.